Search
24/08/2023
Factors associated with the need of parenteral nutrition in critically ill patients after the initiation of enteral nutrition therapy.
Lopez-Delgado JC, Servia-Goixart L, Grau-Carmona T, Bordeje-Laguna L, Portugal-Rodriguez E, Lorencio-Cardenas C, Vera-Artazcoz P, Macaya-Redin L, Martinez-Carmona JF, Marin Corral J, Flordelís-Lasierra JL, Seron-Arbeloa C, Alcazar-Espin MLN, Navas-Moya E, Aldunate-Calvo S, Nieto Martino B, Martinez de Lagran I. Factors associated with the need of parenteral nutrition in critically ill patients after the initiation of enteral nutrition therapy.. Frontiers in Nutrition. 2023; 10DOI:10.3389/fnut.2023.1250305. PMID:37693244. IF:4.000(Q2/3D).
23/08/2023
Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium
Carmona-Rocha, E, Puig, L. Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium. Immunotherapy. 2023; 15(15)DOI:10.2217/imt-2023-0013. PMID:37609785. IF:2.700(Q3/7D).
23/08/2023
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA)
Pereyra-Rodríguez J.J., Poveda J.L., Rivero A., Serra-Baldrich E., Silvestre J.F., Armario-Hita J.C., Calleja M.Á., Carrascosa J.M., Flórez Á., Herranz P., Comellas M., Ortiz de Frutos F.J.. Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA). JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19432. PMID:37594914. IF:8.500(Q1/1D).
23/08/2023
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
van Lennep, JER, Tokgozoglu, LS, Badimon, L, Dumanski, SM, Gulati, M, Hess, CN, Holven, KB, Kavousi, M, Kayikcioglu, M, Lutgens, E, Michos, ED, Prescott, E, Stock, JK, Tybjaerg-Hansen, A, Wermer, MJH, Benn, M. Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society. EUROPEAN HEART JOURNAL. 2023; 44(39)DOI:10.1093/eurheartj/ehad472. PMID:37611089. IF:38.100(Q1/1D).
22/08/2023
Arterial tortuosity syndrome: Phenotypic features and cardiovascular manifestations in 4 newly identified patients
Esmel-Vilomara R., Valenzuela I., Riaza L., Rodríguez-Santiago B., Rosés-Noguer F., Boronat S., Sabaté-Rotés A.. Arterial tortuosity syndrome: Phenotypic features and cardiovascular manifestations in 4 newly identified patients. European Journal of Medical Genetics. 2023; 66(9)DOI:10.1016/j.ejmg.2023.104823. PMID:37619836. IF:1.600(Q4/8D).
22/08/2023
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis
Gigante, B, Levy, JH, van Gorp, E, Bartoloni, A, Bochaton-Piallat, ML, Back, M, ten Cate, H, Christersson, C, Ferreiro, JL, Geisler, T, Lutgens, E, Schulman, S, Storey, RF, Thachil, J, Vilahur, G, Liaw, PC, Rocca, B. Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis. EUROPEAN HEART JOURNAL. 2023; 44(32)DOI:10.1093/eurheartj/ehad388. PMID:37439553. IF:38.100(Q1/1D).